Component
Pancreatic beta-cell apoptosis
Pancreatic beta-cell apoptosis. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Chromium picolinate attenuated the pancreatic beta-cell apoptosis associated with iron excess in the rat experiment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chromium-research/41108476.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c71767b7a3b58e61b7961f55febf9d637807fe598539f4257a3b1e40fe03fb3", "start_char": 0, "end_char": 1865, "text_sha256": "7c71767b7a3b58e61b7961f55febf9d637807fe598539f4257a3b1e40fe03fb3"}
- experimental_model
- Five-group iron-excess supplementation experiment; 30 rats
- exposure
- Eight weeks; adequate or excessive iron as iron citrate with three chromium-picolinate dose levels
- limitations
- Small animal experiment with multiple measured changes. Pathway mediation was proposed, not established by a complete intervention on each signaling node; no human treatment or dietary rescue claim.
- nutrient_topic
- Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
- organism
- Male Wistar rats
- plain_language
- The iron-challenged rats showed less pancreatic-cell injury with chromium treatment.
- primary_references
- [chromium-p41108476] Chromium Mitigates the Iron-Induced Glucose Metabolism Disorder via the PI3K/Akt/Bcl-2 Signaling Pathway: An In Vivo Study in Wistar Rats. (2026). https://pubmed.ncbi.nlm.nih.gov/41108476/ DOI: 10.1007/s12011-025-04867-9
- tissue_or_cell_type
- Pancreatic tissue and systemic glucose measures
Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 809–820
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Five-group iron-excess supplementation experiment; 30 rats · source_derived_draft · unverified_draft
### chromium-iron-rat-beta-cell-apoptosis Chromium picolinate attenuated the pancreatic beta-cell apoptosis associated with iron excess in the rat experiment. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: The iron-challenged rats showed less pancreatic-cell injury with chromium treatment. organism: Male Wistar rats tissue_or_cell_type: Pancreatic tissue and systemic glucose measures experimental_model: Five-group iron-excess supplementation experiment; 30 rats limitations: Small animal experiment with multiple measured changes. Pathway mediation was proposed, not established by a complete intervention on each signaling node; no human treatment or dietary rescue claim. exposure: Eight weeks; adequate or excessive iron as iron citrate with three chromium-picolinate dose levels evidence_span: {"source_cache": "artifacts/chromium-research/41108476.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c71767b7a3b58e61b7961f55febf9d637807fe598539f4257a3b1e40fe03fb3", "start_char": 0, "end_char": 1865, "text_sha256": "7c71767b7a3b58e61b7961f55febf9d637807fe598539f4257a3b1e40fe03fb3"} [chromium-p41108476] Chromium Mitigates the Iron-Induced Glucose Metabolism Disorder via the PI3K/Akt/Bcl-2 Signaling Pathway: An In Vivo Study in Wistar Rats. (2026). https://pubmed.ncbi.nlm.nih.gov/41108476/ DOI: 10.1007/s12011-025-04867-9
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.